Annual Total Assets
$780.35 M
+$116.37 M+17.53%
31 December 2023
Summary:
Iovance Biotherapeutics annual total assets is currently $780.35 million, with the most recent change of +$116.37 million (+17.53%) on 31 December 2023. During the last 3 years, it has risen by +$11.89 million (+1.55%). IOVA annual total assets is now at all-time high.IOVA Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$991.12 M
+$26.79 M+2.78%
30 September 2024
Summary:
Iovance Biotherapeutics quarterly total assets is currently $991.12 million, with the most recent change of +$26.79 million (+2.78%) on 30 September 2024. Over the past year, it has increased by +$138.80 million (+16.29%). IOVA quarterly total assets is now at all-time high.IOVA Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IOVA Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +17.5% | +16.3% |
| 3 y3 years | +1.6% | +19.6% |
| 5 y5 years | +62.3% | +150.4% |
IOVA Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +17.5% | at high | +81.5% |
| 5 y | 5 years | at high | +126.4% | at high | +243.8% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Iovance Biotherapeutics Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $991.12 M(+2.8%) |
| June 2024 | - | $964.32 M(+10.9%) |
| Mar 2024 | - | $869.83 M(+11.5%) |
| Dec 2023 | $780.35 M(+17.5%) | $780.35 M(-8.4%) |
| Sept 2023 | - | $852.32 M(+12.5%) |
| June 2023 | - | $757.29 M(-8.2%) |
| Mar 2023 | - | $824.77 M(+24.2%) |
| Dec 2022 | $663.98 M(-14.6%) | $663.98 M(+21.6%) |
| Sept 2022 | - | $545.92 M(-10.6%) |
| June 2022 | - | $610.88 M(-12.9%) |
| Mar 2022 | - | $701.25 M(-9.8%) |
| Dec 2021 | $777.33 M(+1.2%) | $777.33 M(-6.2%) |
| Sept 2021 | - | $828.83 M(-2.8%) |
| June 2021 | - | $852.79 M(+13.6%) |
| Mar 2021 | - | $750.57 M(-2.3%) |
| Dec 2020 | $768.46 M(+123.0%) | $768.46 M(-1.8%) |
| Sept 2020 | - | $782.29 M(-4.3%) |
| June 2020 | - | $817.57 M(+183.6%) |
| Mar 2020 | - | $288.30 M(-16.4%) |
| Dec 2019 | $344.65 M(-28.3%) | $344.65 M(-12.9%) |
| Sept 2019 | - | $395.75 M(-9.2%) |
| June 2019 | - | $435.92 M(-5.5%) |
| Mar 2019 | - | $461.50 M(-4.0%) |
| Dec 2018 | $480.82 M(+209.5%) | $480.82 M(+77.5%) |
| Sept 2018 | - | $270.83 M(-4.9%) |
| June 2018 | - | $284.75 M(-7.3%) |
| Mar 2018 | - | $307.25 M(+97.7%) |
| Dec 2017 | $155.37 M(-9.6%) | $155.37 M(-10.7%) |
| Sept 2017 | - | $173.97 M(+26.1%) |
| June 2017 | - | $138.01 M(-11.2%) |
| Mar 2017 | - | $155.39 M(-9.6%) |
| Dec 2016 | $171.89 M | $171.89 M(-5.7%) |
| Sept 2016 | - | $182.32 M(-5.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2016 | - | $193.54 M(+92.1%) |
| Mar 2016 | - | $100.77 M(-4.6%) |
| Dec 2015 | $105.65 M(+127.2%) | $105.65 M(-5.9%) |
| Sept 2015 | - | $112.22 M(-2.2%) |
| June 2015 | - | $114.74 M(+1.1%) |
| Mar 2015 | - | $113.54 M(+144.1%) |
| Dec 2014 | $46.51 M(+134.0%) | $46.51 M(+167.0%) |
| Sept 2014 | - | $17.42 M(-6.0%) |
| June 2014 | - | $18.54 M(+2.5%) |
| Mar 2014 | - | $18.08 M(-9.0%) |
| Dec 2013 | $19.87 M(>+9900.0%) | $19.87 M(>+9900.0%) |
| Sept 2013 | - | $168.60 K(-71.8%) |
| June 2013 | - | $597.70 K(+2012.0%) |
| Mar 2013 | - | $28.30 K(-3.7%) |
| Dec 2012 | $29.40 K(-94.8%) | $29.40 K(+2.4%) |
| Sept 2012 | - | $28.70 K(-56.3%) |
| June 2012 | - | $65.60 K(-14.6%) |
| Mar 2012 | - | $76.80 K(-86.5%) |
| Dec 2011 | $568.40 K(-61.1%) | $568.40 K(-83.5%) |
| Sept 2011 | - | $3.44 M(+637.6%) |
| June 2011 | - | $466.20 K(-49.9%) |
| Mar 2011 | - | $930.20 K(-36.3%) |
| Dec 2010 | $1.46 M(>+9900.0%) | $1.46 M(+43.2%) |
| Sept 2010 | - | $1.02 M(+135.2%) |
| June 2010 | - | $433.70 K(-19.1%) |
| Mar 2010 | - | $536.40 K(+5487.5%) |
| Dec 2009 | $9600.00(+71.4%) | $9600.00(+284.0%) |
| Sept 2009 | - | $2500.00(-24.2%) |
| June 2009 | - | $3300.00(-15.4%) |
| Mar 2009 | - | $3900.00(-30.4%) |
| Dec 2008 | $5600.00 | $5600.00(-71.7%) |
| Sept 2008 | - | $19.80 K(-6.2%) |
| June 2008 | - | $21.10 K(-41.4%) |
| Mar 2008 | - | $36.00 K |
FAQ
- What is Iovance Biotherapeutics annual total assets?
- What is the all time high annual total assets for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics annual total assets year-on-year change?
- What is Iovance Biotherapeutics quarterly total assets?
- What is the all time high quarterly total assets for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics quarterly total assets year-on-year change?
What is Iovance Biotherapeutics annual total assets?
The current annual total assets of IOVA is $780.35 M
What is the all time high annual total assets for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high annual total assets is $780.35 M
What is Iovance Biotherapeutics annual total assets year-on-year change?
Over the past year, IOVA annual total assets has changed by +$116.37 M (+17.53%)
What is Iovance Biotherapeutics quarterly total assets?
The current quarterly total assets of IOVA is $991.12 M
What is the all time high quarterly total assets for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high quarterly total assets is $991.12 M
What is Iovance Biotherapeutics quarterly total assets year-on-year change?
Over the past year, IOVA quarterly total assets has changed by +$138.80 M (+16.29%)